Cargando…
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
BACKGROUND: A combination of hepatitis B immunoglobulin and nucleos(t)ide analogues is the current standard of care for controlling hepatitis B recurrence after orthotopic liver transplantation (OLT). However, frequent immunoglobulin treatment is expensive and inconvenient. This study investigated t...
Autores principales: | Takaki, Akinobu, Yagi, Takahito, Yasunaka, Tetsuya, Sadamori, Hiroshi, Shinoura, Susumu, Umeda, Yuzo, Yoshida, Ryuichi, Sato, Daisuke, Nobuoka, Daisuke, Utsumi, Masashi, Yasuda, Yuko, Nakayama, Eiichi, Miyake, Yasuhiro, Ikeda, Fusao, Shiraha, Hidenori, Nouso, Kazuhiro, Fujiwara, Toshiyoshi, Yamamoto, Kazuhide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889285/ https://www.ncbi.nlm.nih.gov/pubmed/23435670 http://dx.doi.org/10.1007/s00535-013-0763-8 |
Ejemplares similares
-
Enhancement of Programmed Death Ligand 2 on Hepatitis C Virus Infected Hepatocytes by Calcineurin Inhibitors
por: Koike, Kazuko, et al.
Publicado: (2015) -
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury
por: Lleo, Ana, et al.
Publicado: (2022) -
Systemic inflammation as fuel for acute liver injury in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2021) -
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
por: Campos-Murguía, Alejandro, et al.
Publicado: (2021) -
Hepatocellular liver injury in hospitalized patients affected by COVID-19: Presence of different risk factors at different time points
por: Leo, M., et al.
Publicado: (2022)